Array BioPharma a randomized, double-blind, double-dunny, active- and placebo- controlled, parallel-arm, 4- week study to investigate the analgesic efficacy and safety of XXXXX in patients with pain due to osteoarthritis of the knee
Astellas A randomized, double-blind, double-dummy, parallel group study to compare XXXXX bid and qd doses and enoxaparin for prevention of venous thromboembolism in subjects undergoing elective hip replacement surgery: A phase IIb study to evaluate the efficacy and safety of XXXXX compared to enoxaparin in subjects undergoing elective hip replacement surgery
Eli Lilly A Phase 2 randomized study to investigate the efficacy and safety of XXXXX versus placebo in older patients undergoing elective total hip arthroplasty (eTHA)
Novum a double-blind, randomized, placebo-controlled, parallel group, multi-site study to evaluate the clinical equivalence of XXXXX with XXXXX in patients with osteoarthritis of the knee
Pfizer A phase 3, multi-center, randomized, double-blind, controlled study of the long term analgesic efficacy and safety of XXXXX alone or in combination with non-steroidal anti-inflammatory drugs (NSAIDS) versus NSAIDS along in patients with osteoarthritis of the knee or hip
Pfizer A phase 3 randomized, double-blind, placebo-controlled multicenter study of XXXXX on peripheral nerve function in patients with osteoarthritis
Pfizer A phase 3 randomized, double-blind, placebo- and oxycodone-controlled, multicenter study of the efficacy and safety of XXXXX in patients with osteoarthritis of the knee or hip
Purdue Pharma A randomized, double-blind, placebo-controlled, multicenter trial with an enriched study design to assess the efficacy and safety of XXXXX compared to placebo in opioid-experienced subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy
QRx Pharma a randomized, double-blind study of the analgesic efficacy and safety of flexible dose XXXXX versus low dose XXXXX in patients who have undergone primary unilateral total knee arthroplasty
Stryker a phase 2, double blind, randomized, placebo-controlled, proof of concept, dose finding study of XXXXX in subjects with osteoarthritis of the knee
Stryker an open label, safety extension study of repeat dosing with XXXXX in subjects with osteoarthritis of the knee
